BCL2 and schizophrenia: As previous studies have demonstrated decreased Bcl-2 levels, increased Bax/Bcl-2 ratio and unaltered Caspase-3, it was proposed that increased vulnerability to pro-apoptotic stimuli occurred in the early stages of schizophrenia, but not in chronic schizophrenia.